Growth Metrics

VitaNova Life Sciences (YJGJ) Current Deferred Revenue (2025)

VitaNova Life Sciences (YJGJ) has disclosed Current Deferred Revenue for 1 consecutive years, with $4286.0 as the latest value for Q4 2025.